$16.19
-0.48[-2.88%]
Last update: 12:22PM Get Real Time Here
Guardant Health
(NASDAQ:GH)Latest News for Guardant Health Stock (NASDAQ:GH)
Guardant Health Stock (NASDAQ: GH)
Categories: All
Monday, April 15, 2024
Friday, April 05, 2024
Thursday, March 28, 2024
Wednesday, March 20, 2024
Wednesday, March 13, 2024
Friday, February 23, 2024
- Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal TestVandana Singh - Feb 23, 2024, 1:35PM
- 4 Analysts Have This To Say About Guardant HealthBenzinga Insights - Feb 23, 2024, 1:01PM
- Guardant Health shares are trading lower after the company issued 2024 revenue guidance with a midpoint below estimates.Benzinga Newsdesk - Feb 23, 2024, 10:33AM
- Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $45Benzinga Newsdesk - Feb 23, 2024, 9:42AM
Thursday, February 22, 2024
- Guardant Health Expects Full Year 2024 Revenue Of $655M-$670M, Est $669.36MBenzinga Newsdesk - Feb 22, 2024, 4:31PM
- Guardant Health: Q4 Earnings InsightsBenzinga Insights - Feb 22, 2024, 4:10PM
- Guardant Health Q4 Adj EPS $(0.64) Beats $(0.87) Estimate, Sales $155.05M Beat $149.57M EstimateBenzinga Newsdesk - Feb 22, 2024, 4:09PM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Tuesday, January 30, 2024
Monday, January 29, 2024
Monday, January 08, 2024
Thursday, December 21, 2023
- Guardant Health shares are trading higher. The company announced a $90.7 million registered direct offering with Baillie Gifford of 3,387,446 shares of its common stock at $26.77 per share.Benzinga Newsdesk - Dec 21, 2023, 11:44AM
- Guardant Health Announces $90.7M Registered Direct Offering With Baillie Gifford Of 3,387,446 Shares Of Its Common Stock At An Offering Price Of $26.77 Per ShareBenzinga Newsdesk - Dec 21, 2023, 9:07AM
Wednesday, December 20, 2023
- Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: AnalystVandana Singh - Dec 20, 2023, 2:07PM
- S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' NowShanthi Rexaline - Dec 20, 2023, 7:17AM
Tuesday, December 19, 2023
Thursday, December 14, 2023
Wednesday, December 13, 2023
Monday, December 04, 2023
Thursday, November 30, 2023
Tuesday, November 28, 2023
Friday, November 17, 2023
Wednesday, November 15, 2023
- Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today?Vandana Singh - Nov 15, 2023, 2:28PM
- Guardant Health shares are trading lower. The company said it intends to appeal yesterday's verdict in the U.S. District Court for the District of Delaware related to intellectual property claims brought by TwinStrand Biosciences University of Washington.Benzinga Newsdesk - Nov 15, 2023, 12:13PM
- Guardant Health To Appeal Federal District Court Verdict Related To Intellectual Property ClaimsBenzinga Newsdesk - Nov 15, 2023, 3:30AM
Monday, November 13, 2023
- Guardant Health shares are trading higher after Raymond James upgraded the stock from Market Perform to Outperform.Benzinga Newsdesk - Nov 13, 2023, 12:56PM
- 7 Analysts Have This to Say About Guardant HealthBenzinga Insights - Nov 13, 2023, 8:00AM
- Raymond James Upgrades Guardant Health to Outperform, Announces $27 Price TargetBenzinga Newsdesk - Nov 13, 2023, 7:26AM
Sunday, November 12, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
- Guardant Health Raises 2023 Revenue Guidance To $553M-$556M Vs $549.06M Est.Benzinga Newsdesk - Nov 6, 2023, 4:50PM
- Guardant Health Q3 2023 Adj EPS $(0.67) Beats $(0.95) Estimate, Sales $143.03M Beat $137.37M EstimateBenzinga Newsdesk - Nov 6, 2023, 4:16PM
- Earnings Scheduled For November 6, 2023Benzinga Insights - Nov 6, 2023, 8:24AM
Monday, October 23, 2023
- Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $45Benzinga Newsdesk - Oct 23, 2023, 8:47AM
- Guardant Health Announces Initial Results From The PEGASUS Trial Show Promise For Use Of Liquid Biopsy To Guide Adjuvant Treatment Of Colon CancerBenzinga Newsdesk - Oct 23, 2023, 4:32AM